STEMSOFT Software Inc. has put in the Progress® DataDirect Connect® for ADO.NET Entity Framework provider for the Oracle database in its cell-therapy manufacturing software. This will enhance application performance and deliver a flexible, secure connection to Oracle, DB2, Sybase, and Microsoft SQL Server. This company delivers end-to-end technology solutions for information management, quality assurance and regulatory compliance used by cellular therapy manufacturers, cord blood banks and clinical blood and marrow transplantation centers.

Its products support the collection, processing, storage, distribution and analysis of high-quality cell therapy, gene therapy and immune therapy products and ensure FDA regulations are met. With this Entity Framework from Microsoft, the products deliver hospitals and research laboratories with an HL7-compliant interface for the exchange of information between systems.  Since most of its customers use a Microsoft SQL Server database or Oracle database, STEMSOFT saw a need for reliable, high-performance database connectivity that could support heterogeneous database environments.

Learn more about STEMSOFT's decision to use DataDirect!